Technology

Ultimovacs is developing a universal cancer vaccine applicable across a broad spectrum of cancer types.

Technology

Clinical studies

Lead product tested in three clinical trials, strong results justifies the initiation of a registration trial.

Clinical studies

News

Ultimovacs acquires the immunotherapy technology business of Immuneed AB

News